Quotient Sciences – UK Headquarters – Nottingham, UK
Mere Way
Ruddington, Nottingham
NG11 6JS
T: +44 115 974 9000

Quotient Sciences – Philadelphia, PA
3080 McCann Farm Drive
Garnet Valley, PA 19060
T: 1 800 769 3518
Linkedin: https://www.linkedin.com/company/quotient-sciences
Twitter: https://twitter.com/Quotient_Sci
Facebook: https://www.facebook.com/quotientsciences
Instagram: https://www.instagram.com/quotient_sci
Youtube: https://www.youtube.com/@quotientsciences

Molecule to cure. Fast.

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.

Integrated drug development programs

We offer fully integrated development, manufacturing, and clinical testing services for small molecules and peptides at all stages of development.

  • Candidate development – support when selecting the right molecules for development, offering expertise that shortens timelines to the clinic
  • Early development – fast and effective support to accelerate molecules from first-in-human (FIH) through to proof of concept (POC)
  • Late development – scaling up molecules for registration/validation and commercial launch, at no expense to speed or quality

Translational Pharmaceutics®: Our flagship platform for fully integrated drug development

For over 15 years and over 1,000 molecules, Quotient Sciences’ Translational Pharmaceutics® platform for drug development has helped global pharma and biotechs accelerate their molecule to market. By integrating drug substance, drug product, and clinical testing activities under a single provider, Translational Pharmaceutics® has been proven to shorten development times by an average of 12 months or more, minimize risk and significantly reduce R&D costs.

Our expertise in understanding dependencies between drug substance properties, formulation design, and clinical outcomes enables us to enhance development efficiency. Having both drug substance and drug product manufacturing activities under one organization allows us to deliver integrated chemistry, manufacturing, and controls (CMC) development activities for both pre-clinical and clinical studies in parallel, simplifying the supply chain and improving the likelihood of downstream clinical and commercial success.

Tailored Services

  • Drug substance synthesis and manufacturing – customized and tailored to each program, building a deep knowledge of molecule developability.
  • Formulation development – experts in complex formulation development for modified release, solubility enhancement and pediatrics
  • Clinical trial manufacturing – a streamlined, flexible approach to drug product supply that reflects your clinical study design and timeline
  • Clinical pharmacology – rapid study startup and recruitment through our clinical units in Miami, FL, US and Nottingham, UK
  • Data sciences – fast access to reliable data is critical for decision making during a study
  • Commercial manufacturing – trusted, global services for reliable commercial supply, including support for high-potency compounds
  • Bioanalysis – world-class expertise, delivering rapid bioanalytical data to support drug development milestones
  • Drug development consulting – expertise at all stages of development, from candidate development through commercial launch

Featured Resources

  1. Info Sheet: Charles River and Quotient Sciences Collaboration
  2. Whitepaper: Assessing the financial impact of Translational Pharmaceutics®
  3. Whitepaper: Strategies to accelerate modified release formulations
  4. Whitepaper: Accelerate the development of orphan drugs 
  5. Info Sheet: ADME capabilities
  6. Info Sheet: Drug substance capabilities
  7. Info Sheet: Pediatrics development capabilities
  8. Info Sheet: Bioanalysis capabilities